| Serial Number | 79186567 |
| Word Mark | LIPID INCODE |
| Filing Date | Monday, March 7, 2016 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, February 9, 2024 |
| Registration Number | 5248111 |
| Registration Date | Tuesday, July 25, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 9, 2017 |
| Goods and Services | Diagnostic preparations for medical or veterinary purposes; products, reagents and indicators for medical diagnostics, namely, preparations, reagents and biological indicators for monitoring the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) for medical or veterinary purposes; Diagnostic agents for medical purposes, namely, diagnostic agents for pharmaceutical use; testing materials for medical use, namely, medical diagnostic reagents and assays for testing of body fluids; pharmaceutical and veterinary products, namely, pharmaceutical products for the treatment of Hypercholesterolemia; food supplements for humans or animals; nutraceutical products for therapeutic use and as a dietary supplement, namely, nutraceuticals for the treatment of Hypercholesterolemia and nutraceuticals for use as a dietary supplement; Plasters for medical purposes, namely, material for dressings; disinfectants |
| Goods and Services | Medical services; diagnosis of diseases, namely, medical diagnosis of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical diagnostic services, testing and analysis, namely, medical diagnostic testing, monitoring and reporting services; genetic testing for diagnostics or treatments for medical purposes; medical information services provided on the Internet, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical consultation and information services in the field of medical products, namely, providing information relating to diagnostic, prophylactic and treatment of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical, medicinal and pharmaceutical consultation services; medical advisory services; medical information services, namely, providing medical information; medical analyses for the diagnosis and treatment of people, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposes, namely, medical testing relating to the diagnosis and treatment of people; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of samples obtained from patients; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples obtained from patients |
| NOT AVAILABLE | "LIPID" |
| Goods and Services | Surgical, medical, dental and veterinary instruments and apparatus, namely, medical instruments and apparatus for use in a genetic diagnostic kit in the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) procedures; suture materials; instruments and apparatus for medical diagnostics, namely, apparatus for medical diagnostic testing in the fields of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase); automatic analyzers for medical diagnostics, namely, medical diagnostic instruments for the analysis of body fluids; apparatus for diagnostic testing for medical purposes, namely, medical diagnostic apparatus for testing DNA; diagnostic test kits for detecting diseases, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in genetic body fluids testing; apparatus for analyzing DNA in biological samples for medical use; apparatus for collecting samples of body fluids, namely, medical specimen collection devices in the nature of glass slides, cups or bags for the collection of blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in storing blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in collecting blood or saliva samples; Sample preparation device for medical diagnostic uses, namely, sample preparation columns for medical use; containers for medical samples, namely, blood and saliva containers for medical purposes; devices for taking samples for medical use, namely, medical devices for obtaining body fluid samples; urine sample testing instruments for medical diagnostics in the nature of medical diagnostic apparatus for testing DNA; containers specially designed for transporting samples containing living human cells; holders for sample containers, namely, specimen cup holders; capillary tubes for samples |
| Goods and Services | Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project study, namely, scientific study and research in the field of the prevention, treatment and management of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical research laboratory services; design and development of apparatus for medical diagnostics; computer-assisted diagnostic testing services, namely, diagnostic services in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; Scientific laboratory services, namely, preparation of biological samples for research purposes; Scientific laboratory services, namely, preparation of biological samples for use in testing and analysis in research laboratories |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 9, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 9, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 9, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 9, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GENINCODE U.K., LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | FERRER INCODE, S.L. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | FERRER INCODE, S.L. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | FERRER INCODE, S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Thursday, May 5, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 6, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 10, 2016 | APPLICATION FILING RECEIPT MAILED |
| Monday, June 20, 2016 | ASSIGNED TO EXAMINER |
| Monday, June 27, 2016 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 28, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 28, 2016 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 28, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 16, 2016 | REFUSAL PROCESSED BY IB |
| Monday, October 3, 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 3, 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 25, 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, January 26, 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, February 3, 2017 | TEAS PETITION TO REVIVE RECEIVED |
| Friday, February 3, 2017 | PETITION TO REVIVE-GRANTED |
| Friday, February 3, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 6, 2017 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, February 16, 2017 | ASSIGNED TO LIE |
| Saturday, February 18, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 18, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 27, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 27, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 27, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 27, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 27, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 31, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, April 19, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 19, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 19, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, May 5, 2017 | NOTIFICATION PROCESSED BY IB |
| Tuesday, May 9, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 9, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 25, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, October 25, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, November 3, 2017 | FINAL DISPOSITION PROCESSED |
| Friday, November 3, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, November 24, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, November 20, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, November 20, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, December 18, 2020 | CHANGE OF OWNER RECEIVED FROM IB |
| Friday, July 9, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, July 25, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Saturday, December 24, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, February 9, 2024 | CANCELLED SECTION 71 |
| Thursday, October 10, 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Thursday, October 24, 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, October 24, 2024 | INVALIDATION PROCESSED |
| Saturday, November 9, 2024 | TOTAL INVALIDATION PROCESSED BY THE IB |